Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation（ADPT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
adpt · 股价预测 · 17 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 17 位华尔街分析师
Buy
17 位分析师
共识
评级分布
12 个月目标价
High
$22.00
Consensus
$21.33
+23.2% upside
Low
$21.00
Median: $21 · Last Close: $17.32
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$21.33
23.2% upside
High Target
$22
27.0%
Low Target
$21
21.2%
Current Price
$17.32
as of today
Based on analyst price targets, the ADPT stock price prediction for the next 12 months ranges from $21 to $22. The consensus ADPT price forecast of $21.33 implies 23.2% upside from the current price of $17.32.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $18.19 | ↑ 5.00% |
1-day model range: $18.04–$18.33. Peak: $18.33 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | +2.0% |
| 2028 | $18 | +3.2% |
| 2029 | $18 | +3.9% |
| 2030 | $18 | +4.3% |
| 2031 | — | +4.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADPT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-05-06 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-06 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-06 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-06 | BTIG | Maintains | Buy→Buy |
| 2026-02-06 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-02-06 | BTIG | Maintains | Buy→Buy |
| 2026-01-26 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-11 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-11-06 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Adaptive Biotechnologies Corporation (ADPT) stock. Of the recent 81 rating actions, 4 were upgrades and 11 were downgrades. 17 analysts currently cover ADPT.
分析师推荐趋势
ADPT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$286M
↓ 33.1% YoY
Revenue Next Year
$350M
↑ 22.4% YoY
EPS This Year
$-0.46
EPS Next Year
$-0.25
↓ 46.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADPT EPS of $-0.46 for the current fiscal year, based on estimates from 6 analysts. The ADPT revenue forecast is $286M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ADPT 股价预测由两类独立数据源支撑：来自 17 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ADPT 的共识目标价为 $21.33（+23.2% 上行空间），分析师共识为 Buy。
ADPT 的短期预测（明日）为 $18.19（+5.00%）。 ADPT 对 2027 年的股价预测均值为 $18。 ADPT 对 2030 年的预测区间为 $16–$20。
Adaptive Biotechnologies Corporation 在 NASDAQ 上市，代码 ADPT。ADPT 在 2027 年的整体展望偏积极，在覆盖分析师中约 65% 对应 Buy 共识。
常见问题
ADPT 预测 · 8 个问题根据 17 位华尔街分析师，ADPT 的 12 个月平均目标价为 $21.33，最高 $22.00、最低 $21.00。若有图表，中位目标价可在上方查看。相对当前价 $17.32，隐含约 +23.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.